Exact Mass: 815.609727

PC(18:0/20:1(11Z))

C46H90NO8P (815.640371)

PC(18:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(14:0/24:1(15Z))

C46H90NO8P (815.640371)

PC(14:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/24:1(15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(14:1(9Z)/24:0)

C46H90NO8P (815.640371)

PC(14:1(9Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/24:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(16:0/22:1(13Z))

C46H90NO8P (815.640371)

PC(16:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of erucic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(16:1(9Z)/22:0)

C46H90NO8P (815.640371)

PC(16:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/22:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(11Z)/20:0)

C46H90NO8P (815.640371)

PC(18:1(11Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/20:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(9Z)/20:0)

C46H90NO8P (815.640371)

PC(18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/20:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:0/18:1(11Z))

C46H90NO8P (815.640371)

PC(20:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:0/18:1(9Z))

C46H90NO8P (815.640371)

PC(20:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of oleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:1(11Z)/18:0)

C46H90NO8P (815.640371)

PC(20:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of stearic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:0/16:1(9Z))

C46H90NO8P (815.640371)

PC(22:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/16:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:1(13Z)/16:0)

C46H90NO8P (815.640371)

PC(22:1(13Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))

C48H82NO7P (815.5828592)

PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The docosahexaenoic acid moiety is derived from fish oils, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))

C48H82NO7P (815.5828592)

PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The docosahexaenoic acid moiety is derived from fish oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The docosahexaenoic acid moiety is derived from fish oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(24:0/14:1(9Z))

C46H90NO8P (815.640371)

PC(24:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/14:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(24:1(15Z)/14:0)

C46H90NO8P (815.640371)

PC(24:1(15Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/14:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of myristic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C48H82NO7P (815.5828592)

PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C48H82NO7P (815.5828592)

PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of docosahexaenoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the docosahexaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(16:0/24:1(15Z))

C46H90NO8P (815.640371)

PE-NMe(16:0/24:1(15Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(16:1(9Z)/24:0)

C46H90NO8P (815.640371)

PE-NMe(16:1(9Z)/24:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/24:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:0/22:1(13Z))

C46H90NO8P (815.640371)

PE-NMe(18:0/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(11Z)/22:0)

C46H90NO8P (815.640371)

PE-NMe(18:1(11Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/22:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(9Z)/22:0)

C46H90NO8P (815.640371)

PE-NMe(18:1(9Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/20:1(11Z))

C46H90NO8P (815.640371)

PE-NMe(20:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/20:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:1(11Z)/20:0)

C46H90NO8P (815.640371)

PE-NMe(20:1(11Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/20:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:0/18:1(11Z))

C46H90NO8P (815.640371)

PE-NMe(22:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:0/18:1(9Z))

C46H90NO8P (815.640371)

PE-NMe(22:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:1(13Z)/18:0)

C46H90NO8P (815.640371)

PE-NMe(22:1(13Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/18:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(24:0/16:1(9Z))

C46H90NO8P (815.640371)

PE-NMe(24:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:0/16:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(24:1(15Z)/16:0)

C46H90NO8P (815.640371)

PE-NMe(24:1(15Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:1(15Z)/16:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(15:0/24:1(15Z))

C46H90NO8P (815.640371)

PE-NMe2(15:0/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:1(15Z)/15:0)

C46H90NO8P (815.640371)

PE-NMe2(24:1(15Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/15:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE(22:0/18:1(12Z)-O(9S,10R))

C45H86NO9P (815.6039876)

PE(22:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(22:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(18:1(12Z)-O(9S,10R)/22:0)

C45H86NO9P (815.6039876)

PE(18:1(12Z)-O(9S,10R)/22:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-O(9S,10R)/22:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(22:0/18:1(9Z)-O(12,13))

C45H86NO9P (815.6039876)

PE(22:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(22:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(18:1(9Z)-O(12,13)/22:0)

C45H86NO9P (815.6039876)

PE(18:1(9Z)-O(12,13)/22:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(9Z)-O(12,13)/22:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

Phosphatidylcholine 20:0-18:1

C46H90NO8P (815.640371)

halicerebroside A

C46H89NO10 (815.6486134)

(2R)-2-hydroxy-N-[(2S,3S,4R,16E)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)oxy-16-icosen-2-yl]icosanamide|pakistamide B

C46H89NO10 (815.6486134)

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9Z)-2-[(2R)-2-hydroxydocosanoylamino]-9-octadecene-1,3,4-triol

C46H89NO10 (815.6486134)

(2S,3S,4R,8Z)-1-O-(beta-D-galactopyranosyl)-2N-[(2R)-2-hydroxy-19(Z)-docosanoylamino]-8(Z)-octadecene-1,3-4-triol

C46H89NO10 (815.6486134)

PC 38:1

C46H90NO8P (815.640371)

Found in mouse brain; TwoDicalId=466; MgfFile=160720_brain_AA_19_Neg; MgfId=1990 Found in mouse heart; TwoDicalId=3434; MgfFile=160902_Heart_EPA_Neg_09; MgfId=1343

(2-{[2-(docosanoyloxy)-3-[hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)

PC(16:0/22:1)[U]

C46H90NO8P (815.640371)

PC(18:0/20:1)

C46H90NO8P (815.640371)

PC(18:1/20:0)

C46H90NO8P (815.640371)

PC(18:1/20:0)[U]

C46H90NO8P (815.640371)

PC(20:0/18:1)[U]

C46H90NO8P (815.640371)

PC(20:0/18:1)

C46H90NO8P (815.640371)

1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine

C48H82NO7P (815.5828592)

Lecithin

C46H90NO8P (815.640371)

Lecithin

C48H82NO7P (815.5828592)

PC(16:0/22:1(11Z))

C46H90NO8P (815.640371)

PC(17:1(9Z)/21:0)

C46H90NO8P (815.640371)

PC(19:0/19:1(9Z))

C46H90NO8P (815.640371)

PC(19:1(9Z)/19:0)

C46H90NO8P (815.640371)

PC(21:0/17:1(9Z))

C46H90NO8P (815.640371)

PC(22:1(11Z)/16:0)

C46H90NO8P (815.640371)

PE(19:0/22:1(11Z))

C46H90NO8P (815.640371)

PE(19:1(9Z)/22:0)

C46H90NO8P (815.640371)

PE(20:1(11Z)/21:0)

C46H90NO8P (815.640371)

PE(21:0/20:1(11Z))

C46H90NO8P (815.640371)

PE(22:0/19:1(9Z))

C46H90NO8P (815.640371)

PE(22:1(11Z)/19:0)

C46H90NO8P (815.640371)

PS(P-20:0/19:1(9Z))

C45H86NO9P (815.6039876)

PC O-40:8

C48H82NO7P (815.5828592)

PE 41:1

C46H90NO8P (815.640371)

PS O-39:2

C45H86NO9P (815.6039876)

HexCer 40:1;O4

C46H89NO10 (815.6486134)

1-eicosanoyl-2-[(11Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z)-octadecenoyl respectively.

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

PE(22:0/18:1(12Z)-O(9S,10R))

C45H86NO9P (815.6039876)

PE(18:1(12Z)-O(9S,10R)/22:0)

C45H86NO9P (815.6039876)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] docosanoate

C45H86NO9P (815.6039876)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] docosanoate

C45H86NO9P (815.6039876)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

2-[[(E,2S,3R)-2-[[(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoylamino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoylamino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H84N2O9P+ (815.5914124000001)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[3-tetracosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

HexCer 9:1;2O/34:5

C49H85NO8 (815.627485)

HexCer 9:0;2O/34:6

C49H85NO8 (815.627485)

HexCer 25:1;2O/18:5

C49H85NO8 (815.627485)

HexCer 11:0;2O/32:6

C49H85NO8 (815.627485)

HexCer 19:3;2O/24:3

C49H85NO8 (815.627485)

HexCer 21:0;2O/22:6

C49H85NO8 (815.627485)

HexCer 19:2;2O/24:4

C49H85NO8 (815.627485)

HexCer 23:1;2O/20:5

C49H85NO8 (815.627485)

HexCer 27:2;2O/16:4

C49H85NO8 (815.627485)

HexCer 11:1;2O/32:5

C49H85NO8 (815.627485)

HexCer 13:0;2O/30:6

C49H85NO8 (815.627485)

HexCer 13:1;2O/30:5

C49H85NO8 (815.627485)

HexCer 21:3;2O/22:3

C49H85NO8 (815.627485)

HexCer 21:1;2O/22:5

C49H85NO8 (815.627485)

HexCer 15:0;2O/28:6

C49H85NO8 (815.627485)

HexCer 15:1;2O/28:5

C49H85NO8 (815.627485)

HexCer 13:2;2O/30:4

C49H85NO8 (815.627485)

HexCer 17:3;2O/26:3

C49H85NO8 (815.627485)

HexCer 25:2;2O/18:4

C49H85NO8 (815.627485)

HexCer 17:0;2O/26:6

C49H85NO8 (815.627485)

HexCer 19:1;2O/24:5

C49H85NO8 (815.627485)

HexCer 25:3;2O/18:3

C49H85NO8 (815.627485)

HexCer 21:2;2O/22:4

C49H85NO8 (815.627485)

HexCer 17:2;2O/26:4

C49H85NO8 (815.627485)

HexCer 23:3;2O/20:3

C49H85NO8 (815.627485)

HexCer 15:2;2O/28:4

C49H85NO8 (815.627485)

HexCer 27:3;2O/16:3

C49H85NO8 (815.627485)

HexCer 19:0;2O/24:6

C49H85NO8 (815.627485)

HexCer 15:3;2O/28:3

C49H85NO8 (815.627485)

HexCer 23:2;2O/20:4

C49H85NO8 (815.627485)

HexCer 17:1;2O/26:5

C49H85NO8 (815.627485)

[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-[3-nonanoyloxy-2-[(15Z,18Z,21Z,24Z,27Z)-triaconta-15,18,21,24,27-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

Lnape 20:0/N-21:1

C46H90NO8P (815.640371)

Lnape 18:1/N-23:0

C46H90NO8P (815.640371)

Lnape 21:0/N-20:1

C46H90NO8P (815.640371)

Lnape 20:1/N-21:0

C46H90NO8P (815.640371)

Lnape 14:1/N-27:0

C46H90NO8P (815.640371)

Lnape 26:1/N-15:0

C46H90NO8P (815.640371)

Lnape 21:1/N-20:0

C46H90NO8P (815.640371)

Lnape 26:0/N-15:1

C46H90NO8P (815.640371)

Lnape 23:0/N-18:1

C46H90NO8P (815.640371)

Lnape 19:0/N-22:1

C46H90NO8P (815.640371)

Lnape 25:0/N-16:1

C46H90NO8P (815.640371)

Lnape 17:1/N-24:0

C46H90NO8P (815.640371)

Lnape 17:0/N-24:1

C46H90NO8P (815.640371)

Lnape 15:1/N-26:0

C46H90NO8P (815.640371)

Lnape 16:1/N-25:0

C46H90NO8P (815.640371)

Lnape 15:0/N-26:1

C46H90NO8P (815.640371)

Lnape 22:0/N-19:1

C46H90NO8P (815.640371)

Lnape 24:0/N-17:1

C46H90NO8P (815.640371)

Lnape 22:1/N-19:0

C46H90NO8P (815.640371)

Lnape 24:1/N-17:0

C46H90NO8P (815.640371)

Lnape 27:0/N-14:1

C46H90NO8P (815.640371)

Lnape 19:1/N-22:0

C46H90NO8P (815.640371)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-heptadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[3-henicosanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[3-[(Z)-pentadec-9-enoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-nonadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[3-[(Z)-henicos-11-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[3-pentadecanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C49H85NO8 (815.627485)

HexCer 9:0;3O/31:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 8:0;3O/32:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 12:0;3O/28:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 10:0;3O/30:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 13:0;3O/27:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 13:1;3O/27:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 12:1;3O/28:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 11:0;3O/29:1;(2OH)

C46H89NO10 (815.6486134)

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C50H89NO5S (815.6461104)

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

C50H89NO5S (815.6461104)

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C50H89NO5S (815.6461104)

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C50H89NO5S (815.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (Z)-pentadec-9-enoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate

C48H82NO7P (815.5828592)

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C50H89NO5S (815.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propan-2-yl] (Z)-heptadec-9-enoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C48H82NO7P (815.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C48H82NO7P (815.5828592)

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexacosane-1-sulfonic acid

C50H89NO5S (815.6461104)

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

C50H89NO5S (815.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C48H82NO7P (815.5828592)

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C50H89NO5S (815.6461104)

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-heptadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-amino-3-[[3-[(Z)-docos-13-enoxy]-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[2-icosanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-henicosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(Z)-nonadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-docosoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[2-pentadecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonadecoxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tricosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-henicosoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(Z)-henicos-11-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-nonadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-amino-3-[hydroxy-[3-pentadecoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-heptadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-amino-3-[[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-nonadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(Z)-hexacos-15-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-docosanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-amino-3-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetracos-13-enoxy]propoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-[(Z)-hexacos-15-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[hydroxy-[3-icosoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tricosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C45H86NO9P (815.6039876)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

2-[4-[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C48H81NO7S (815.5733436)

2-[4-[3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C52H81NO6 (815.6063566)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-octacos-17-enoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-triacont-19-enoate

C46H90NO8P (815.640371)

Cer 14:0;2O/19:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/18:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/22:6;(3OH)(FA 16:4)

C53H85NO5 (815.6427399999999)

Cer 14:0;2O/20:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)

Cer 19:0;2O/18:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 16:0;2O/21:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 18:0;2O/16:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/18:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)

Cer 17:0;2O/16:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)

Cer 17:0;2O/16:5;(3OH)(FA 20:5)

C53H85NO5 (815.6427399999999)

Cer 18:0;2O/19:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 14:0;2O/20:6;(3OH)(FA 19:4)

C53H85NO5 (815.6427399999999)

Cer 16:0;2O/19:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)

Cer 16:0;2O/16:5;(3OH)(FA 21:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/22:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/16:5;(3OH)(FA 22:5)

C53H85NO5 (815.6427399999999)

Cer 16:0;2O/18:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/19:5;(3OH)(FA 19:5)

C53H85NO5 (815.6427399999999)

Cer 17:0;2O/20:6;(3OH)(FA 16:4)

C53H85NO5 (815.6427399999999)

Cer 21:0;2O/16:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 17:0;2O/20:5;(3OH)(FA 16:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/16:4;(3OH)(FA 22:6)

C53H85NO5 (815.6427399999999)

Cer 14:0;2O/18:5;(3OH)(FA 21:5)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/20:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)

Cer 14:0;2O/19:4;(3OH)(FA 20:6)

C53H85NO5 (815.6427399999999)

Cer 15:0;2O/20:6;(3OH)(FA 18:4)

C53H85NO5 (815.6427399999999)

Cer 14:0;2O/21:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)

Cer 17:0;2O/18:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)

Cer 19:0;2O/16:5;(3OH)(FA 18:5)

C53H85NO5 (815.6427399999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C48H82NO7P (815.5828592)

Lpc 40:8-SN1

C48H82NO7P (815.5828592)

HexCer 22:1;3O/18:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 28:0;3O/12:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 19:1;3O/21:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 16:1;3O/24:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 24:1;3O/16:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 26:1;3O/14:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 19:0;3O/21:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 16:0;3O/24:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 23:1;3O/17:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 21:1;3O/19:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 25:0;3O/15:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 15:1;3O/25:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 20:1;3O/20:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 26:0;3O/14:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 17:1;3O/23:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 15:0;3O/25:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 21:0;3O/19:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 22:0;3O/18:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 14:0;3O/26:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 24:0;3O/16:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 18:0;3O/22:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 27:1;3O/13:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 14:1;3O/26:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 18:1;3O/22:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 25:1;3O/15:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 17:0;3O/23:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 20:0;3O/20:1;(2OH)

C46H89NO10 (815.6486134)

HexCer 28:1;3O/12:0;(2OH)

C46H89NO10 (815.6486134)

HexCer 27:0;3O/13:1;(2OH)

C46H89NO10 (815.6486134)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H82NO7P (815.5828592)

[3-octanoyloxy-2-[(Z)-triacont-19-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-dotriacont-21-enoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] tetracosanoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

C46H90NO8P (815.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] docosanoate

C46H90NO8P (815.640371)

[3-decanoyloxy-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-icosanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-docosanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-pentacosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-henicosanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[2-[(Z)-tetracos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[3-dodecanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

(5E,8E,11E,14E)-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadeca-4,8-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

C49H85NO8 (815.627485)

[(2S)-3-tetracosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[(E)-pentadec-9-enoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] (E)-docos-13-enoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] hexacosanoate

C46H90NO8P (815.640371)

[(2R)-2-tetracosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-hexacos-5-enoate

C46H90NO8P (815.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-tetracos-15-enoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (E)-docos-13-enoate

C46H90NO8P (815.640371)

[(2R)-2-[(E)-tetracos-15-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] tetracosanoate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-henicosanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2S)-3-docosanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] pentacosanoate

C46H90NO8P (815.640371)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] henicosanoate

C46H90NO8P (815.640371)

[(2R)-3-[(E)-icos-13-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)

[(2S)-3-henicosanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

C46H90NO8P (815.640371)

[(2R)-3-dodecanoyloxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] tetracosanoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] henicosanoate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] tricosanoate

C46H90NO8P (815.640371)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2S)-2-dodecanoyloxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] pentacosanoate

C46H90NO8P (815.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] pentacosanoate

C46H90NO8P (815.640371)

[(2S)-3-[(E)-tetracos-15-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-3-[(E)-icos-11-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] henicosanoate

C46H90NO8P (815.640371)

[(2R)-3-icosanoyloxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H90NO8P (815.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] tricosanoate

C46H90NO8P (815.640371)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoyl]amino]trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(4E,8E,12E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(E)-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoyl]amino]-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C48H84N2O6P+ (815.6066674000001)

1-tetradecanoyl-2-[(15Z)-tetracosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (15Z)-tetracosenoyl respectively.

1-octadecanoyl-2-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-eicosenoyl respectively.

1-hexadecanoyl-2-[(13Z)-docosenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (13Z)-docosenoyl respectively.

1-[(9Z)-octadecenoyl]-2-eicosanoyl-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and eicosanoyl respectively.

1-eicosanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are eicosanoyl and (9Z)-octadecenoyl respectively.

PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C48H82NO7P (815.5828592)

PE-NMe(16:0/24:1(15Z))

C46H90NO8P (815.640371)

phosphatidylcholine 38:1

C46H90NO8P (815.640371)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 1 double bond.

phosphatidylcholine (18:1/20:0)

C46H90NO8P (815.640371)

A phosphatidylcholine 38:1 in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C20:0 respectively.

MePC(37:1)

C46H90NO8P (815.640371)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(42:7)

C48H81NO9 (815.5911016)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(39:1)

C46H90NO8P (815.640371)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(43:6)

C49H85NO8 (815.627485)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(40:1)

C46H89NO10 (815.6486134)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 36:0;O2

C46H89NO10 (815.6486134)

DGCC 38:6;O

C48H81NO9 (815.5911016)

DGCC 39:5

C49H85NO8 (815.627485)

DGTS 38:6;O2

C48H81NO9 (815.5911016)

DGTS 39:5;O

C49H85NO8 (815.627485)

PC O-18:0/20:2;O

C46H90NO8P (815.640371)

PC O-18:2/22:6

C48H82NO7P (815.5828592)

PC O-20:0/18:2;O

C46H90NO8P (815.640371)

PC O:20:5/20:4

C48H82NO7P (815.5828592)

PC O-38:2;O

C46H90NO8P (815.640371)

PC P-18:1/22:6

C48H82NO7P (815.5828592)

PC P-18:1/22:6 or PC O-18:2/22:6

C48H82NO7P (815.5828592)

PC P-20:0/18:1;O

C46H90NO8P (815.640371)

PC P-40:7

C48H82NO7P (815.5828592)

PC P-40:7 or PC O-40:8

C48H82NO7P (815.5828592)

PC 12:0_26:1

C46H90NO8P (815.640371)

PC 14:0_24:1

C46H90NO8P (815.640371)

PC 14:0/24:1(15Z)

C46H90NO8P (815.640371)

PC 14:1_24:0

C46H90NO8P (815.640371)

PC 15:1_23:0

C46H90NO8P (815.640371)

PC 16:0_22:1

C46H90NO8P (815.640371)

PC 16:0/22:1

C46H90NO8P (815.640371)

PC 16:0/22:1(13Z)

C46H90NO8P (815.640371)

PC 16:1_22:0

C46H90NO8P (815.640371)

PC 16:1(7Z)/22:0

C46H90NO8P (815.640371)

PC 17:1_21:0

C46H90NO8P (815.640371)

PC 18:0_20:1

C46H90NO8P (815.640371)

PC 18:0/20:1

C46H90NO8P (815.640371)

PC 18:1_20:0

C46H90NO8P (815.640371)

PC 20:0/18:1

C46H90NO8P (815.640371)

PC 34:0/4:1

C46H90NO8P (815.640371)

LNAPE 40:2;O

C45H86NO9P (815.6039876)

LNAPE 41:1

C46H90NO8P (815.640371)

PE O-20:0/20:3;O2

C45H86NO9P (815.6039876)

PE O-40:3;O2

C45H86NO9P (815.6039876)

PE 20:0/20:2;O

C45H86NO9P (815.6039876)

PE 22:0/18:2;O

C45H86NO9P (815.6039876)

PE 22:1/18:1;O

C45H86NO9P (815.6039876)

PE 40:2;O

C45H86NO9P (815.6039876)

PE 14:1_27:0

C46H90NO8P (815.640371)

PE 15:0_26:1

C46H90NO8P (815.640371)

PE 15:1_26:0

C46H90NO8P (815.640371)

PE 16:1_25:0

C46H90NO8P (815.640371)

PE 17:0_24:1

C46H90NO8P (815.640371)

PE 17:1_24:0

C46H90NO8P (815.640371)

PE 18:1_23:0

C46H90NO8P (815.640371)

PE 19:0_22:1

C46H90NO8P (815.640371)

PE 20:1_21:0

C46H90NO8P (815.640371)

PE 37:0/4:1

C46H90NO8P (815.640371)

PS O-16:2/23:0

C45H86NO9P (815.6039876)

PS O-18:2/21:0

C45H86NO9P (815.6039876)

PS O-20:2/19:0

C45H86NO9P (815.6039876)

PS O-22:0/17:2

C45H86NO9P (815.6039876)

PS O-22:1/17:1

C45H86NO9P (815.6039876)

PS O-22:2/17:0

C45H86NO9P (815.6039876)

PS P-16:1/23:0

C45H86NO9P (815.6039876)

PS P-16:1/23:0 or PS O-16:2/23:0

C45H86NO9P (815.6039876)

PS P-18:1/21:0

C45H86NO9P (815.6039876)

PS P-18:1/21:0 or PS O-18:2/21:0

C45H86NO9P (815.6039876)

PS P-20:1/19:0

C45H86NO9P (815.6039876)

PS P-20:1/19:0 or PS O-20:2/19:0

C45H86NO9P (815.6039876)

PS P-22:0/17:1

C45H86NO9P (815.6039876)

PS P-22:0/17:1 or PS O-22:1/17:1

C45H86NO9P (815.6039876)

PS P-22:1/17:0

C45H86NO9P (815.6039876)

PS P-22:1/17:0 or PS O-22:2/17:0

C45H86NO9P (815.6039876)

PS P-39:1

C45H86NO9P (815.6039876)

PS P-39:1 or PS O-39:2

C45H86NO9P (815.6039876)

GalCer 19:2;O2/24:4

C49H85NO8 (815.627485)

GalCer 21:0;O2/22:6

C49H85NO8 (815.627485)

GalCer 21:1;O2/22:5

C49H85NO8 (815.627485)

GalCer 21:2;O2/22:4

C49H85NO8 (815.627485)

GalCer 43:6;O2

C49H85NO8 (815.627485)

GlcCer 19:2;O2/24:4

C49H85NO8 (815.627485)

GlcCer 21:0;O2/22:6

C49H85NO8 (815.627485)

GlcCer 21:1;O2/22:5

C49H85NO8 (815.627485)

GlcCer 21:2;O2/22:4

C49H85NO8 (815.627485)

GlcCer 43:6;O2

C49H85NO8 (815.627485)

HexCer 19:2;O2/24:4

C49H85NO8 (815.627485)

HexCer 21:0;O2/22:6

C49H85NO8 (815.627485)

HexCer 21:1;O2/22:5

C49H85NO8 (815.627485)

HexCer 21:2;O2/22:4

C49H85NO8 (815.627485)

HexCer 43:6;O2

C49H85NO8 (815.627485)

GDCAE 26:6

C52H81NO6 (815.6063566)

GLCAE 27:5

C53H85NO5 (815.6427399999999)

TDCAE 22:3

C48H81NO7S (815.5733436)

TLCAE 23:2

C49H85NO6S (815.609727)

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

C46H89NO10 (815.6486134)

(2r)-n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxydocosanimidic acid

C46H89NO10 (815.6486134)

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-6-en-2-yl)-2-hydroxydocosanimidic acid

C46H89NO10 (815.6486134)